It’s Thanksgiving week and, as most of our listeners know, it’s time when Inside Workers’ Comp celebrates our annual tradition by presenting our “Why We’re Thankful for Workers’ Comp” episode. This year, we open the floor to members of our Enlyte parent brand and pose the question to key players in our industry: Rebecca Morgan, VP, Product Management, Mitchell; Anne Levins, SVP, Network Product & Analytics, Coventry; and Debbi Gillespie, RN, CCM, Heart of Case Management Award Winner, Genex. Listen and learn why they believe this year’s Thanksgiving will be extra special for workers’ comp professionals.
More stories
Data Analytics in Insurance Claims Processing: Trends & Benefits
Using data analytics in insurance claims processing can create a variety of benefits if done right, including identifying trends before they become problems and helping claims organizations develop data-driven business strategies.
Psychedelics as Medicine? A Look at Alternative Treatments for Mental Health Conditions
Are psychedelics the next “miracle” drug to treat mental health conditions? We will outline the current understanding of psychedelics and where they could possibly fit into treatment in the future.
Workers' Comp 2021 Technology Trends Report
One year after the start of the COVID-19 pandemic, we wanted to know: How has technology use changed over the past year in the workers’ compensation industry and how will those changes sustain through into the future?
Webinar: The Whole Person Approach
Identifying social determinants of health to assist in recovery and return to work Case managers have long known the importance of gettin
Coventry Webinar: Long COVID and the Enduring Challenges for Workers
Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation.
ODG Updates Muscle Relaxant Formulary
The updates move several skeletal muscle relaxant drugs to "N" status on the drug formulary.